Back to Search Start Over

Yangambin and Epi-yangambin Isomers: New Purification Method from Ocotea fasciculata and First Cytotoxic Aspects Focusing on In Vivo Safety.

Authors :
Martins J
Coelho J
Tadini MC
de Souza RO
Figueiredo SA
Fonseca MJV
de Albuquerque NCP
Lopes NP
Berretta A
Marquele-Oliveira F
de Oliveira ARM
Source :
Planta medica [Planta Med] 2020 Apr; Vol. 86 (6), pp. 415-424. Date of Electronic Publication: 2020 Mar 03.
Publication Year :
2020

Abstract

Ocotea fasciculata presents yangambin (YAN) and its isomer epi-yangambin (EPI-YAN) as major lignans, which are employed as the plant markers for quality control purposes and as potential pharmacological compounds. However, a gap between the pure isomers and safety and efficacy protocols is faced by the scientific community. In this context, this work aimed to report (i) a new and advantageous purifying process in a semi-preparative scale for YAN and EPI-YAN isolation from Ocotea fasciculata , and (ii) an in vitro cytotoxicity study to estimate, for the first time, the LD <subscript>50</subscript> values of the isolated epimers, as well as the influence of albumin concentration in cell culture medium. The best condition for epimers isolation was achieved in normal-phase liquid chromatography. The lignan fraction (LF), previously obtained from the plant ethanolic extract, was purified yielding 17% and 29% of YAN and EPI-YAN, respectively. The in vitro study demonstrated that YAN and EPI-YAN were safe, and only at the highest concentration studied, a decrease on cell viability was observed. The estimated LD <subscript>50</subscript> value was higher than 1612 mg/kg for both epimers. The LF, on the other hand, demonstrated an estimated LD <subscript>50</subscript> of 422 mg/kg. Lignan cytotoxicity studies also evidenced that the higher cell viability was related to the higher concentration of fetal bovine serum as a source of albumin in medium. This is the first time the LD <subscript>50</subscript> and safety of the isolated epimers were estimated, opening up great perspectives of success in in vivo studies.<br />Competing Interests: The authors declare that they have no conflict of interest.<br /> (Georg Thieme Verlag KG Stuttgart · New York.)

Subjects

Subjects :
Plant Extracts
Furans
Lignans
Ocotea

Details

Language :
English
ISSN :
1439-0221
Volume :
86
Issue :
6
Database :
MEDLINE
Journal :
Planta medica
Publication Type :
Academic Journal
Accession number :
32126582
Full Text :
https://doi.org/10.1055/a-1118-3828